IL17A and hypertensive disorder: Studies have shown that the expression or secretion of numerous immune factors, such as IL-17, MCP-1, IL-6, TGF-β, and IL-10, is regulated by the microbiome or its metabolites, potentially impacting hypertension (Yang et al., 2022).